Elotuzumab: no benefit for older patients with newly diagnosed multiple myeloma Comment

被引：0
|
作者：
Touzeau, Cyrille [1 ,2 ]
机构：
[1] Univ Hosp Hotel Dieu, Dept Hematol, F-44093 Nantes, France
[2] CNRS, Ctr Rech Cancerol & Immunol Integree Nantes Anger, INSERM, UMR 6075,UMR 1307, Nantes, France
来源：
LANCET HAEMATOLOGY | 2022年 / 9卷 / 06期
关键词：
TRANSPLANT-INELIGIBLE PATIENTS; OPEN-LABEL; DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB; PHASE-3;
D O I：
10.1016/S2352-3026(22)00132-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E386 / E387
页数：2
相关论文
共 50 条
  • [1] Elotuzumab: no additional effect in patients with newly diagnosed multiple myeloma
    Tamura, Hideto
    LANCET HAEMATOLOGY, 2024, 11 (02): : e86 - e87
  • [2] Quality of Life Assessment in Older Patients with Newly-Diagnosed Multiple Myeloma
    Mian, Hira
    Fiala, Mark
    Pond, Gregory
    Wildes, Tanya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E232 - E233
  • [3] Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies
    Fakhri, Bita
    Fiala, Mark A.
    Tuchman, Sascha A.
    Wildes, Tanya M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (03): : 219 - 224
  • [4] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [5] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    Blood Cancer Journal, 9
  • [6] Geriatric Assessment in Older Adults with Newly Diagnosed Multiple Myeloma
    Wildes, Tanya M.
    Depp, Brittany
    Vij, Ravi
    Stockerl-Goldstein, Keith
    Colditz, Graham
    BLOOD, 2014, 124 (21)
  • [7] Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma
    Mian, Hira
    Fiala, Mark
    Wildes, Tanya M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (02): : 98 - +
  • [8] The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
    Ang Li
    Qian Wu
    Greg Warnick
    Shan Li
    Edward N. Libby
    David A. Garcia
    Gary H. Lyman
    Annals of Hematology, 2020, 99 : 121 - 126
  • [9] Utilization of Autologous Stem Cell Transplantation in Older Patients with Newly Diagnosed Multiple Myeloma
    King, Justin
    Fiala, Mark A.
    Goldsmith, Scott R.
    Stockerl-Goldstein, Keith E.
    Schroeder, Mark A.
    Ghobadi, Armin
    Vij, Ravi
    Wildes, Tanya M.
    BLOOD, 2019, 134
  • [10] The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
    Li, Ang
    Wu, Qian
    Warnick, Greg
    Li, Shan
    Libby, Edward N.
    Garcia, David A.
    Lyman, Gary H.
    ANNALS OF HEMATOLOGY, 2020, 99 (01) : 121 - 126
12345